Trial intelligence / Profile preview

Methylprednisolone Combined with Electroacupuncture for POCD in Elderly Patients

NCT02535039Phase 2Unknown

Sponsor
Shengjing Hospital of China Medical University
Start
Oct 2015
Primary completion
Dec 2016
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of methylprednisolone injection in Post-operative cognitive dysfunction (POCD), sponsored by Shengjing Hospital of China Medical University. Status: unknown.

02

Drugs

methylprednisolone injection
03

Conditions

Post-operative cognitive dysfunction (POCD)

Beyond the preview

Go deeper on NCT02535039.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02535039.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call